[R01] PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
Ente: National Institute on Aging
Scadenza: 2027-01-31
Importo max: $1,353,297
Paese: US
Descrizione
PROJECT SUMMARY/ABSTRACT
Women are at greater life-time risk for Alzheimer’s disease (AD). One potential factor contributing to greater life-
time risk of AD is the midlife menopausal endocrine aging transition when multiple AD risk conditions can emerge
and which are consistent with prodromal / pre
Settori: National Institute on Aging
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.